August 12, 2015 / 5:42 AM / 2 years ago

BRIEF-Bionor Pharma Q2 EBITDA loss widens to NOK 18.6 million

Aug 12 (Reuters) - Bionor Pharma ASA :

* Q2 revenue 15,000 Norwegian crowns ($1,816.62) versus 564,000 crowns year ago

* Q2 EBITDA loss 18.6 million crowns versus loss 14.3 million crowns year ago

* Q2 net loss 21.3 million crowns versus loss 17.0 million crowns year ago

* Maintains its financial guidance for 2015

* For full year 2015, expects core cost base to be in range of 55 million - 63 million crowns

* Management is currently exploring funding options beyond 2015 either by equity, debt, bonds, or a combination thereof

Source text for Eikon:

Further company coverage: ($1 = 8.2571 Norwegian crowns) (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below